Literature DB >> 12796336

Nephrology: 4. Strategies for the care of adults with chronic kidney disease.

Caroline Stigant1, Lesley Stevens, Adeera Levin.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12796336      PMCID： PMC156688     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  50 in total

1.  Clinical practice guidelines for initiation of dialysis. Canadian Society of Nephrology.

Authors:  D N Churchill; P G Blake; K K Jindal; E B Toffelmire; M B Goldstein
Journal:  J Am Soc Nephrol       Date:  1999-06       Impact factor: 10.121

2.  Clinical practice guidelines for vascular access. Canadian Society pf Nephrology.

Authors:  J H Ethier; R M Lindsay; P E Barre; J E Kappel; E J Carlisle; A Common
Journal:  J Am Soc Nephrol       Date:  1999-06       Impact factor: 10.121

3.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

4.  1999 Canadian recommendations for the management of hypertension. Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension.

Authors:  R D Feldman; N Campbell; P Larochelle; P Bolli; E D Burgess; S G Carruthers; J S Floras; R B Haynes; G Honos; F H Leenen; L A Leiter; A G Logan; M G Myers; J D Spence; K B Zarnke
Journal:  CMAJ       Date:  1999       Impact factor: 8.262

5.  A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The SLEEPO study).

Authors:  R L Benz; M R Pressman; E T Hovick; D D Peterson
Journal:  Am J Kidney Dis       Date:  1999-12       Impact factor: 8.860

6.  Normalizing hematocrit in dialysis patients improves brain function.

Authors:  J L Pickett; D C Theberge; W S Brown; S U Schweitzer; A R Nissenson
Journal:  Am J Kidney Dis       Date:  1999-06       Impact factor: 8.860

7.  Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria.

Authors:  P Ruggenenti; A Perna; G Gherardi; G Garini; C Zoccali; M Salvadori; F Scolari; F P Schena; G Remuzzi
Journal:  Lancet       Date:  1999-07-31       Impact factor: 79.321

8.  Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

Authors:  G L Bakris; M R Weir
Journal:  Arch Intern Med       Date:  2000-03-13

9.  Elevated levels of serum creatinine: recommendations for management and referral.

Authors:  D C Mendelssohn; B J Barrett; L M Brownscombe; J Ethier; D E Greenberg; S D Kanani; A Levin; E B Toffelmire
Journal:  CMAJ       Date:  1999-08-24       Impact factor: 8.262

Review 10.  Anaemia in the patient with renal insufficiency: documenting the impact and reviewing treatment strategies.

Authors:  A Levin
Journal:  Nephrol Dial Transplant       Date:  1999-02       Impact factor: 5.992
View more
  7 in total

1.  Nephrology care in Canada.

Authors:  Keevin Bernstein; Claudio Rigatto
Journal:  CMAJ       Date:  2003-11-11       Impact factor: 8.262

Review 2.  Guidelines for the management of chronic kidney disease.

Authors:  Adeera Levin; Brenda Hemmelgarn; Bruce Culleton; Sheldon Tobe; Philip McFarlane; Marcel Ruzicka; Kevin Burns; Braden Manns; Colin White; Francoise Madore; Louise Moist; Scott Klarenbach; Brendan Barrett; Robert Foley; Kailash Jindal; Peter Senior; Neesh Pannu; Sabin Shurraw; Ayub Akbari; Adam Cohn; Martina Reslerova; Vinay Deved; David Mendelssohn; Gihad Nesrallah; Joanne Kappel; Marcello Tonelli
Journal:  CMAJ       Date:  2008-11-18       Impact factor: 8.262

3.  Assessment and modeling of routinely used biochemical laboratory data of healthy individuals and end-stage renal failure (ESRF) patients by three different chemometric methods.

Authors:  Agelos Papaioannou; George Rigas; Panagiotis Plageras; George A Karikas; George Karamanis
Journal:  J Clin Lab Anal       Date:  2013-05       Impact factor: 2.352

4.  Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey.

Authors:  Paul Arora; Priya Vasa; Darren Brenner; Karl Iglar; Phil McFarlane; Howard Morrison; Alaa Badawi
Journal:  CMAJ       Date:  2013-05-06       Impact factor: 8.262

5.  Perceptions of prognostic risks in chronic kidney disease: a national survey.

Authors:  Helen H L Chiu; Navdeep Tangri; Ognjenka Djurdjev; Brendan J Barrett; Brenda R Hemmelgarn; François Madore; Claudio Rigatto; Norman Muirhead; Manish M Sood; Catherine M Clase; Adeera Levin
Journal:  Can J Kidney Health Dis       Date:  2015-12-20

6.  Daily Intake of Grape Powder Prevents the Progression of Kidney Disease in Obese Type 2 Diabetic ZSF1 Rats.

Authors:  Salwa M K Almomen; Qiunong Guan; Peihe Liang; Kaidi Yang; Ahmad M Sidiqi; Adeera Levin; Caigan Du
Journal:  Nutrients       Date:  2017-03-31       Impact factor: 5.717

7.  The British Columbia Nephrologists' Access Study (BCNAS) - a prospective, health services interventional study to develop waiting time benchmarks and reduce wait times for out-patient nephrology consultations.

Authors:  Michael E Schachter; Alexandra Romann; Ognjenka Djurdev; Adeera Levin; Monica Beaulieu
Journal:  BMC Nephrol       Date:  2013-08-29       Impact factor: 2.388
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.